Study Details
Full Title
A Phase 2, Single-Arm, Multicenter, Open-Label Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma (XL092-201)
Principal Investigator
Katherine
Peters
Protocol Number
PRO00119908
NCT ID
NCT07428616
Phase
II
Enrollment Status
Open to Enrollment